Filling the need for trusted information on national health issues…

Trending on kff Subsidies Marketplaces Enrollment

Private Sector Involvement

  • your selections
Clear Search

Filter Results

date

Tags

  • results
London Declaration On NTDs Showing Success

Writing in Humanosphere, development blogger Tom Paulson highlights the success of the London Declaration on Neglected Tropical Diseases. “…In the first annual progress report for the London Declaration issued last month, the authors noted the 1.12 billion NTD treatments distributed, new donor funding to help endemic countries develop integrated disease…

Committee On World Food Security Meets In Rome

The Guardian reports on the 40th session of the Committee on World Food Security (CFS), meeting in Rome this week. “Once a relatively mechanistic, high-level event, today the CFS stands alone among big U.N. meetings for bringing everyone to the table and is often hailed the most inclusive global governance…

PPPs ‘Critical To Deliver Messages To New Mothers’

“Lifebuoy joined forces with [USAID] and its Maternal and Child Health Integrated Program (MCHIP) to create a neonatal program to raise awareness of the link between newborn survival and handwashing with soap,” Anila Gopal, global social mission manager at Unilever-Lifebuoy, writes in USAID’s “IMPACTblog.” She continues, “Public-private partnerships are critical…

Report Explores Strategies To Better Address NCDs

“Over the past year I have been involved with the Oxford Martin Commission for Future Generations, a group of international leaders working to identify how progress can be delivered on critical challenges such as addressing the global burden of chronic disease and the risks (and opportunities) associated with our hyper-connected…

Devex Interview Examines Role Of PPPs In Development Of Global Health Technologies

On the sidelines of “a high-level panel discussion held at the European Parliament in Brussels on the value of cross-sectoral partnerships to develop and deliver high-impact, cost-effective global health technologies,” where “speakers discussed the challenges of developing innovative and effective responses targeted at poverty-related and neglected diseases and conditions in…

‘Novel Paradigms’ Needed To Increase R&D Funding For Neglected Diseases

Describing two recent articles criticizing the pharmaceutical industry for not spending more for research and development (R&D) into neglected diseases, John LaMattina, former president of Pfizer Global Research and Development, writes in a Forbes opinion piece, “People have the view that Big Pharma is a cash generating machine. But, the…

Gates Foundation Blog Examines New Vaccine Discovery Partnership

In a post in the Bill & Melinda Gates Foundation’s “Impatient Optimists” blog, Trevor Mundel, president of global health at the foundation, examines the Vaccine Discovery Partnership, “a new initiative that will lead to better and more effective approaches to vaccine research and development.” The new effort “will be a…

Restaurant Creates Bond To Fund Malaria Prevention, Treatment In Mozambique

“Nando’s, the restaurant chain popular for its peri-peri chicken, recently announced a partnership creating the Mozambique Malaria Performance Bond, a development impact bond to fund malaria reduction efforts in Mozambique,” Devex Impact reports. “D. Capital, Dalberg’s impact investing arm, helped Nando’s create the model for the first social impact bond…

GlobalPost Examines Oxfam’s ‘Behind The Brands’ Initiative

GlobalPost’s “Pulse” blog examines how Oxfam is challenging large food companies such as Coca-Cola and Nestle “to identify agricultural policies that could be perpetuating hunger, poverty and human rights abuses.” The blog states, “As part of the project, called ‘Behind the Brands,’ Oxfam is acting as a sort of consultant…

Blog Examines Drug Donation Programs, Big Pharma’s Role In Public Health Agenda

“Drug donations, reinvestment of profits in developing countries and a more flexible approach to intellectual property have all signaled a more collaborative approach from industry with the likes of GlaxoSmithKline, Sanofi, Johnson & Johnson and Merck all performing well in the 2012 Access to Medicine Initiative,” Adam Robert Green, senior…